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klotho was first described as an aging gene and was later shown to be a regulator of phosphate and
vitamin D metabolism, acting as a coreceptor for FGF23. Imura et al. (2007) now report that klotho
also regulates calcium homeostasis.klotho was identified as a putative
aging gene in 1997 when one of the
mouse strains created in a program
of random insertionalmutagenesiswas
found to be short-lived and displayed
atherosclerosis, osteopenia, skin at-
rophy, and pulmonary emphysema
(Kuro-o et al., 1997). Since these traits
were viewed as evidence of premature
aging, the mutation was named klotho
after the spinner of the thread of life,
one of the three Fates. The klotho gene
encodes a cell-surface protein with a
short cytoplasmic tail whose extracel-
lular domain consists of tandem dupli-
cated copies of a b-glucosidase-like
sequence, which can be released as
a soluble form of Klotho.
It was subsequently found that
klotho mutant mice had markedly in-
creased levels of calcium, phosphate,
and the active metabolite of vitamin
D, 1,25-dihydroxyvitamin D (Tsujikawa
et al., 2003). These animals die prema-
turely because their kidneys and other
tissues become calcified. This, and the
somatic features of the klotho pheno-
type, was reminiscent of mice lacking
the FGF23 gene (Urakawa et al., 2006),
which led to the observation that se-
rum levels of FGF23 were markedly
elevated in klotho mutant mice, thus
establishing that klotho is geneticallydownstream of FGF23. Further exper-
iments showed that binding to Klotho
converts FGF receptors from low-
affinity to high-affinity FGF23 recep-
tors (Urakawa et al., 2006; Kurosu
et al., 2006). Imura et al. (2007) now re-
port that klotho is also a regulator of
calcium homeostasis on its own.
Most of the features that resemble
premature aging in klothomutant mice
are consequences of 1,25-dihydroxy-
vitamin D excess. The life span of
klotho mutant mice can be increased
by a vitamin D-deficient diet (Tsuji-
kawa et al., 2003). Removing the syn-
thetic enzyme for 1,25-dihydroxyvita-
min D from FGF23/ mice abolishes
all the notable features of the corre-
sponding phenotype, which are prob-
ably forms of tissue damage resulting
from chronically high calcium and
phosphate levels (Sitara et al., 2006).
The pathway by which klotho regu-
lates phosphate and vitamin D metab-
olism thus intersects with the newly
discovered FGF23 pathway. FGF23 is
a secreted phosphatonin, a factor that
induces renal phosphate wasting and
inhibits synthesis of 1,25-dihydroxyvi-
tamin D (White et al., 2006). FGF23
causes renal phosphate wasting in
both inherited and acquired forms of
hypophosphatemic rickets. The pre-Cell Metabolismdominant source of FGF23 is osteo-
cytes and osteoblasts in bone, where
its secretion is repressed by dentin
matrix protein 1 (DMP1) (Liu et al.,
2006; Feng et al., 2006; Lorenz-
Depiereux et al., 2006). The secretion
of FGF23 is increased by hyperphos-
phatemia and 1,25-dihydroxyvitamin
D, but the details of its feedback
mechanisms and its physiological
role remain obscure.
klotho is expressed in only three
tissues, the distal tubule of the kid-
ney, parathyroid glands, and choroid
plexus; however, its function in these
tissues is not known. Imura et al.
(2007) report that Klotho interacts
physically with Na+/K+ ATPase in all
three of these tissues. In the choroid
plexus, Klotho binds to Na+/K+ ATP-
ase in an intracellular compartment
and a fraction of Na+/K+ ATPase ap-
pears to traffic to the cell surface with
Klotho. [3H]ouabain binding to Na+/K+
ATPase and 86Rb uptake, a measure
of Na+/K+ ATPase activity, are de-
creased, albeit slightly, in klotho/
mice. The molecular mechanism for
this effect of klotho, however, remains
to be identified.
Imura et al. show that Klotho regu-
lates some aspects of calcium homeo-
stasis. Calcium transport by the choroid6, August 2007 ª2007 Elsevier Inc. 93
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PreviewsFigure 1. Proposed Roles of Klotho and FGF23 in Calcium/Vitamin D and Bone
Metabolism
(A) Proposed roles of Klotho (or Klotho/Na+/K+ ATPase) in calcium homeostasis. Hypocalcemia
stimulates the release of PTH and Klotho. PTH corrects hypocalcemia by increasing renal calcium
reabsorption, renal synthesis of 1,25-dihydroxyvitamin D (1,25(OH)2D), and bone resorption.
Klotho participates in protecting the serum calcium by enhancing secretion of PTH, possibly by
increasing Na+/K+ ATPase activity, and by increasing renal calcium reabsorption.
(B) Proposed role of FGF23/Klotho in matrix mineralization. FGF23 is secreted by osteocytes and
regulates bone matrix mineralization with Klotho as a coreceptor. When bone matrix is undermin-
eralized, FGF23 synthesis is suppressed by a signal from the matrix (carried by DMP1 and Phex).
Low FGF23 levels permit reclamation of phosphate and synthesis of 1,25(OH)2D by the kidneys,
providing the conditions for mineralization. Phosphate and 1,25(OH)2D stimulate secretion of
FGF23 in a feedback loop.plexus is known to be regulated by se-
rum calcium concentration ([Ca2+]); the
authors show that cerebrospinal fluid
[Ca2+] is lower in klotho/ mice than
in klotho+/+mice, which have equivalent
serum [Ca2+]. [3H]ouabain binding and
86Rb uptake are regulated by medium
[Ca2+] in isolated choroid plexus from
klotho+/+, but not klotho/, mice. The
authors infer that calcium- and klotho-
dependent recruitment of Na+/K+
ATPase may be involved in the regula-
tion of transepithelial calcium transport
by the choroid plexus.
The parathyroid glands secrete
parathyroid hormone (PTH) to protect
against hypocalcemia; secretion of
PTH is regulated by a G protein-cou-
pled calcium-sensing receptor (Hofer
and Brown, 2003). Imura et al. (2007)
show that the secretion of PTH in
response to hypocalcemia is blunted
in klotho/mice. Moreover, secretion
of PTH by isolated parathyroid glands
in low [Ca2+] medium is decreased
equivalently in glands from klotho/
mice and in ouabain-treated glands
from klotho+/+ mice, while treatment
of klotho/ glands with ouabain has
no additional effect. These data are
consistent with the possibility that klo-
tho regulates PTH secretion through94 Cell Metabolism 6, August 2007 ª2007effects on Na+/K+ ATPase. However,
the present work does not establish
whether the action (or actions) of klotho
on Na+/K+ ATPase are central to the
effects of klotho on calcium homeo-
stasis. Moreover, because increased
production of 1,25-dihydroxyvitamin
D in klotho/mice causes an increase
in serum calcium with suppression of
PTH, it isn’t clear whether PTH secre-
tory dynamics are altered in vivo as
they are in isolated parathyroids.
Imura et al. make another important
observation—that there is a marked
increase in release of Klotho protein
from choroid plexus, parathyroid, or
kidney incubated in low-[Ca2+] me-
dium. It was previously known that Klo-
tho circulates after release from the cell
surface, but this is the first report that
the process is regulated. Two renal
transporters essential to calcium and
phosphate homeostasis have recently
been shown to be regulated by extra-
cellular Klotho: TRPV5, the PTH- and
vitamin D-responsive calcium trans-
porter in the distal nephron (Chang
et al., 2005), and NaPi2a, the sodium-
coupled phosphate transporter in the
proximal tubule (personal communica-
tion, M. Kuro-o). In both cases, evi-
dence points to cleavage of glycosylElsevier Inc.moieties on the transporter by the b-
glucuronidase activity of Klotho as the
mechanism by which Klotho regulates
surface display; however, this mecha-
nism does not seem to be operational
in the case of Klotho regulation of
Na+/K+ ATPase.
How do the observations of Imura
et al. (2007) fit into the physiology of
calcium homeostasis? The previous
observation that the phenotypes of
FGF23/ and klotho/ mice are
nearly identical (Urakawa et al., 2006)
indicates that many features of Klotho
deficiency result from defective FGF23
action. One possibility is that Klotho, in
addition to being the coreceptor for
FGF23, has other downstream roles.
The primary site of FGF23 action in
the kidney is predicted to be the distal
renal tubule, based on the precise
localization of Klotho protein to that
nephronsegment, but thecells respon-
sible for phosphate reabsorption and
vitamin D activation are in the proximal
tubule. Could Klotho be released at the
site of FGF23 action and serve as an
extracellular second messenger to in-
hibit phosphate reabsorption?
Although the present results are tan-
talizing, it is not yet definite that Klotho
plays an appreciable role in calcium
homeostasis that is independent of
FGF23. Current thoughts regarding
the role of FGF23 and Klotho in cal-
cium/vitamin D and bone metabolism
are summarized in Figure 1. They pre-
dict a circuitous route following the
thread of life through the byways of
mineral ion metabolism.
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